Treatment of recurrent epithelial ovarian cancer
Author:
Affiliation:
1. Department of Urogynecology National Cancer Institute, Pascale Foundation (Scientific Institute for Research and Healthcare) Naples Italy
Publisher
Wiley
Subject
Cancer Research,Oncology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/cncr.32500
Reference34 articles.
1. Harmonising clinical trials within the Gynecologic Cancer InterGroup: consensus and unmet needs from the Fifth Ovarian Cancer Consensus Conference;Bookman MA;Ann Oncol,2017
2. Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease;Wilson K;Ann Oncol,2017
3. 5th Ovarian Cancer Consensus Conference: individualized therapy and patient factors;McGee J;Ann Oncol,2017
4. ESMO‐ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease;Colombo N;Ann Oncol,2019
5. Treatment of patients with recurrent epithelial ovarian cancer for whom platinum is still an option;Buechel M;Ann Oncol,2019
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Anti-cancer effects of benzimidazole derivative BNZ-111 on paclitaxel-resistant ovarian cancer;Gynecologic Oncology;2024-09
2. Machine learning analysis of oxidative stress‐related phenotypes for specific gene screening in ovarian cancer;Environmental Toxicology;2024-08-20
3. Retrospective multicenter study of elderly patients with platinum-sensitive relapsed ovarian cancer treated with trabectedin and pegylated liposomal doxorubicin (pld) in a real-world setting: a geico study;BMC Cancer;2024-07-05
4. Targeted Photodynamic Therapy using a Vectorized Photosensitizer coupled to Folic Acid Analog induces Ovarian Tumor Cell Death and inhibits IL-6-mediated Inflammation;Journal of Controlled Release;2024-07
5. A Review of CAR-T Combination Therapies for Treatment of Gynecological Cancers;International Journal of Molecular Sciences;2024-06-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3